Running Effect on Cardiovascular and Muscular Parameters

August 11, 2012 updated by: Wolfgang Kemmler, University of Erlangen-Nürnberg Medical School

Effect of 16 Weeks of Running Exercise on Parameters Related to the Cardiovascular System, Blood and Muscle in Untrained Males 30-50 Years Old. A Randomized Controlled Study

The purpose of the study is to determine the effect of 16 weeks of running exercise on various parameters related to heart, vascular systems, blood, and muscle in untrained males 30-50 years old.

Further, the investigators assess which of the above mentioned parameters may explain the increase of running performance most accurate.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Erlangen, Germany, 91052
        • Institute of Medical Physics, University of Erlangen-Nurnberg
      • Erlangen, Germany, 91052
        • Institute of Physical Education and Sport Sciences
      • Erlangen, Germany, 91054
        • Departement of Radiology, University of Erlangen-Nurnberg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • males
  • untrained (< 2 endurance exercise sessions/week)
  • 30-50 years old

Exclusion Criteria:

  • pathological changes of the heart
  • inflammable diseases
  • medication/diseases affecting cardiovascular system and muscle
  • very low physical capacity (< 100 Watt at ergometry)
  • obesity (BMI > 30 kg/m2)
  • more than 2 weeks of absence during the interventional period
  • more than 2 exercise session beside the intervention
  • contraindication related to MRI-assessment (i.e. claustrophobia, magnetizable intracorporal artefacts)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control
Experimental: exercise
16 weeks of running exercise
16 week of periodized progressive running exercise 2-4 times/week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
myocardial mass/stroke volume
Time Frame: 4 month
Atrial and ventricular volume and mass indexes were assessed by magnetic resonance imaging (MRI)
4 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
maximal oxygen uptake
Time Frame: 4 month
maximal oxygen uptake during running
4 month
Resting metabolic rate
Time Frame: 4 month
Adaptation of resting metabolic rate to running exercise
4 month
muscle strength/power
Time Frame: 4 month
Isometric muscle strength of the leg extensors Leg power as assessed by counter movement jump
4 month
myocardial volume
Time Frame: 4 month
Functional and morphologic parameters of the heart as assessed by echocardiography
4 month
Intima media thickness
Time Frame: 4 month
Carotid intima media thickness by high-resolution ultrasound
4 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Michael Lell, MD, Departement of Radiology, Division of Cardiology, University of Erlangen-Nurnberg
  • Principal Investigator: Michael Scharf, MD, Departement of Radiology, Division of Cardiology
  • Study Chair: Willi A Kalender, PhD, Institute of Medical Physics, University of Erlangen, Germany
  • Study Chair: Michael Uder, MD, Departement of Radiology, University of Erlangen-Nurnberg
  • Study Director: Wolfgang Kemmler, PhD, Institute of Medical Physics, University of Erlangen-Nurnberg, Germany
  • Principal Investigator: Simon von Stengel, PhD, University of Erlangen-Nürnberg Medical School

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2011

Primary Completion (Actual)

July 1, 2012

Study Completion (Actual)

July 1, 2012

Study Registration Dates

First Submitted

July 18, 2011

First Submitted That Met QC Criteria

July 29, 2011

First Posted (Estimate)

August 1, 2011

Study Record Updates

Last Update Posted (Estimate)

August 14, 2012

Last Update Submitted That Met QC Criteria

August 11, 2012

Last Verified

August 1, 2012

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on exercise

3
Subscribe